Intralesional bleomycin for the treatment of periocular capillary hemangiomas.
Indian J Ophthalmol
;
2012 Jul-Aug; 60(4): 326-328
Article
Dans Anglais
| IMSEAR
| ID: sea-144865
ABSTRACT
Periocular infantile capillary hemangiomas do not always respond well to conventional treatment modalities such as systemic or intralesional corticosteroids, radiotherapy or debulking surgery. The authors describe the use of intralesional bleomycin injections (IBIs) to treat potentially amblyogenic lesions in two cases where other modalities have failed. In both cases monthly IBIs successfully cleared the visual axis of the affected eye before the age of 1 year thus preventing permanent sensory deprivation amblyopia. A total of five and nine injections, respectively, were used and no significant side effects were noted. IBI appears to be a useful alternative in the treatment of periocular capillary hemangiomas refractory to more conventional modalities.
Texte intégral:
Disponible
Indice:
IMSEAR (Asie du Sud-Est)
Sujet Principal:
Bléomycine
/
Femelle
/
Humains
/
Nouveau-né
/
Injections intralésionnelles
/
Amblyopie
/
Hémangiome capillaire
langue:
Anglais
Texte intégral:
Indian J Ophthalmol
Année:
2012
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS